Tag: Philips Respironics
Philips exit skews vent market
March 1, 2024Liz Beaulieu, Editor
YARMOUTH, Maine – With its Trilogy EVO considered the standard bearer, the decision by Philips to exit the home ventilator market in the U.S. is a tough hit, but “business goes on,” say industry players.
“Philips was the industry leader for NIV therapy,” said Elliot Campbell, executive vice president and chief commercial officer for Whitmore Lake, Mich.-based Trace Medical, a supplier of rental ventilators nationally. “But our customers have been in flux...
Rotech provides notification of Philips breach
February 26, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare on Feb. 23 provided notification of a recent privacy incident experienced by Philips Respironics that may have impacted certain information of patients who purchased Philips sleep and respiratory devices from Rotech.
“Although Rotech is unaware of any misuse of information resulting from this event, we are providing this notice in an abundance of caution,” the company stated on its website.
When reached for comment, a spokesman...
Providers feel squeezed in wake of Philips exit
February 2, 2024Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Even after enduring the roller-coaster of doing business with Philips Respironics the past few years, providers were still shocked by the company’s recent announcement that it would stop selling certain respiratory products.
Philips on Jan. 25 announced that it would discontinue selling 19 products in the U.S., including items subject to a recall, like the Trilogy 100/200/202 portable home ventilators. The company will service many of the products until Jan....
Manufacturers seek to ‘take pain away’
February 2, 2024Liz Beaulieu, Editor
YARMOUTH, Maine – The decision by Philips to discontinue its line of oxygen concentrators in the U.S. will leave a significant gap in the market, but manufacturers say they’re ramping up to meet increased demand, with lessons learned from the COVID-19 pandemic and the CPAP recall.
Just prior to announcing it had agreed on the terms of a consent decree related to the recall, Philips announced on Jan. 25 that it was discontinuing sales for 19 products, including the EverFlo home...
Philips agrees to terms of consent decree
January 29, 2024HME News Staff
AMSTERDAM – Philips has agreed on the terms of a multi-year consent decree with the U.S. Food and Drug Administration related to Philips Respironics and its recall of certain sleep and respiratory care devices, providing clarity and a roadmap to demonstrate compliance and to restore the business, the company says.
In the U.S., Respironics will continue to service sleep and respiratory care devices already with health care providers and patients, and supply accessories (including patient...
Philips Respironics to focus on masks, other consumables in US
January 25, 2024HME News Staff
AMSTERDAM – Philips Respironics has released a list of 19 sleep and respiratory products that it will stop selling in the United States as soon as this month, including the EverFlo home oxygen system and the Trilogy EVO and EV300 home ventilators.
“We have streamlined our portfolio to enable us to focus on programs that are best suited to changing market dynamics and will most effectively serve patients and customers in the future,” the company states on its website. “In...
FDA issues warning for DreamStation 2
November 29, 2023HME News Staff
AMSTERDAM – The U.S. Food and Drug Administration yesterday issued a safety communication to inform users of possible thermal issues with the Philips Respironics DreamStation 2 CPAP machine and to advise them to monitor the machines for signs of overheating.
The FDA recently received medical device reports (MDRs) associated with issues like fire, smoke, burns and other signs of overheating while using the machine. The agency is in ongoing discussions with Philips about...
Philips updates complaint count
November 28, 2022HME News Staff
AMSTERDAM – Philips Respironics filed an additional 70,000 medical device reports (MDRs) with the U.S. Food and Drug Administration between April 2022 and October 2022, the company stated in a Nov. 22 update on its recall of certain CPAP, BiPAP and mechanical ventilator devices.
The vast majority of the 90,000 MDRs filed since April 2021 are alleged technical malfunctions that do not involve serious injury, the company stated.
“It is important to note that the submission...
Philips pauses remediation program for vents
November 21, 2022HME News Staff
AMSTERDAM – Philips has temporarily paused its remediation program for its Trilogy 100/200 ventilators while it investigates a limited number of complaints on remediated units.
“We anticipate a several week delay from our initial four- to six-week timeline in providing remediated devices back to our customers,” the company stated in a Nov. 7 update. “Remediating these devices in a timely manner is our top priority. In order to keep remediation progressing once our...
Philips lays off employees ‘to start turning company around’
October 24, 2022HME News Staff
AMSTERDAM – Philips will reduce its workforce by about 4,000 roles globally, the company announced as part of its third quarter financial results.
The immediate restructuring actions will result in EUR 300 million in charges in the coming quarters but will save EUR 300 million annually.
“My immediate priority is to improve execution so that we can start rebuilding the trust of patients, consumers and customers, as well as shareholders and other stakeholders,” stated Roy Jakobs,...